| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Heller Frances K is a Director at Larimar Therapeutics, Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $194K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2017 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 10,000 | $3.90 | $38,988.00 | +26.3% | |
| Dec 19, 2016 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 10,000 | $3.23 | $32,290.00 | +50.0% | |
| Nov 15, 2016 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 10,000 | $3.54 | $35,434.00 | +100.0% | |
| Jul 22, 2016 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 10,000 | $2.99 | $29,900.00 | New |